Vreof Stock Price Target
Curaleaf price target raised to $20 from $14 at roth capital 01/19/21 needham curaleaf price target raised to $18.50 from $14 at needham 01/13/21 canaccord curaleaf price target raised to c$23.50 from c$18.50 at canaccord 01/11/21 roth capital curaleaf credit facility completed on favorable terms, says roth capital 141 rows view the latest news, buy/sell ratings, sec filings and insider transactions for your.
The bull run will continue with a price target of around $150.
Vreof stock price target. The stock price for vireo health international inc ( otc: During the day the stock fluctuated 9.25% from a day low at $1.46 to a day high of $1.60. The upside potential (average analyst target price relative to current price) of vreof is higher than 2.33% of pharmaceutical products stocks.
Current stock price for vireo health international inc (vreof)? According to the issued ratings of 3 analysts in the last year, the consensus rating for jushi stock is buy based on the current 1 hold rating and 2 buy ratings for jushf. The share price of $4.25 represents a 6% premium to sow good’s private placement earlier this year.
The yellow trend line is resistance. Based on analysts offering 12 month price targets for vreof in the last 3 months. This would be a 15.1% increase from current levels.
Closing on may 12 th at $2.09 the stock is down 9.56% in the last 5 days. 23, 2021 at 2:47 p.m. Seeking alpha | may 14, 2021 vireo health to report first quarter 2021 results on may 14, 2021
The stock is down 23.19% in the last 30 days. This would be a 15.1% increase from current levels. Trulieve cannabis stock price target raised to c$81 from c$66 at alliance global partners.
One of the top 25 analysts, according to tipranks.com , recently recommended buy vreof with a $4.00 price target. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. The average price target is $3.30 with a high forecast of $3.30 and a low forecast of $3.30.
I apologize for the scale, i did this on my phone. Learn more on jushf's analyst rating history 22 analyst firms have reported ratings in the last year.
In essence, this would represent an increase of 57.65% from current levels. Vireo health international inc's average analyst price target is greater than 1.47% of all us stocks. The analyst firm set a price target for 33.00 expecting be to rise to within 12 months (a possible 16.44% upside).
The price has been going up and down for this period, and there has been a 2.25% gain for the last 2 weeks. According to analysts at market beat vreof stock has a consensus price target of $2.33 per share. With this in mind, vreof stock could be a prospect for your penny stock watchlist in may.
For this reason, vreof stock could be a marijuana penny stock to watch for some upside in the market. According to analysts at market beat vreof stock has a consensus price target of $2.33 per share. The vireo health international inc stock price gained 7.43% on the last trading day (tuesday, 5th oct 2021), rising from $1.48 to $1.59.
The company’s shares closed last friday at $2.00. Vireo health international (vreof) canaccord genuity analyst matt bottomley maintained a buy rating on vireo health international on may 14 and set a price target of c$4.00. (― upside) based on 1 wall street analysts offering 12 month price targets for vireo health international in the last 3 months.
The orange trend line is support.
Post a Comment for "Vreof Stock Price Target"